PCMC
BSX icon

Paragon Capital Management (Colorado)’s Boston Scientific BSX Stock Holding History

Paragon Capital Management (Colorado)’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-1,739
Closed -$74K – 221
2021
Q4 		$74K Buy
+1,739
New +$73.1K 0.01% 306

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BG
Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return

Paragon Capital Management (Colorado)'s BSX Position: Q1 2022 in Review

Paragon Capital Management (Colorado) sold out of Boston Scientific (BSX) in Q1 2022, closing a stake of 1,739 shares — an estimated $74K sold.

Paragon Capital Management (Colorado) first reported a position in BSX in Q4 2021 and held it in 1 quarter. The position peaked at $74K in Q4 2021. 904 funds tracked by Wall St. Rank hold BSX as of Q1 2022.

  • Paragon Capital Management (Colorado) reported no remaining Boston Scientific position as of Q1 2022 after selling out during the quarter.
  • Paragon Capital Management (Colorado) sold 1,739 Boston Scientific shares in Q1 2022, an estimated $74K.
  • Paragon Capital Management (Colorado) first reported a position in Boston Scientific in Q4 2021 and held it in 1 quarter.
  • Paragon Capital Management (Colorado)'s Boston Scientific position peaked at $74K in Q4 2021.
  • 904 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2022.

Based on Paragon Capital Management (Colorado)'s 13F filing for Q1 2022, filed 19 Apr 2022.